UBS Group’s Concord Medical Services CCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.36K | Sell |
500
-115
| -19% | -$527 | ﹤0.01% | 9357 |
|
|
2026
Q1 | $2.25K | Sell |
615
-248
| -29% | -$994 | ﹤0.01% | 9314 |
|
|
2025
Q4 | $3.33K | Sell |
863
-36,985
| -98% | -$176K | ﹤0.01% | 9048 |
|
|
2025
Q3 | $232K | Sell |
37,848
-30,071
| -44% | -$166K | ﹤0.01% | 6586 |
|
|
2025
Q2 | $389K | Buy |
67,919
+67,702
| +31,199% | +$423K | ﹤0.01% | 6219 |
|
|
2025
Q1 | $868 | Sell |
217
-442
| -67% | -$2.06K | ﹤0.01% | 9633 |
|
|
2024
Q4 | $3.54K | Sell |
659
-264
| -29% | -$1.57K | ﹤0.01% | 8857 |
|
|
2024
Q3 | $6.47K | Buy |
923
+107
| +13% | +$778 | ﹤0.01% | 7970 |
|
|
2024
Q2 | $7.75K | Buy |
+816
| New | +$5.47K | ﹤0.01% | 7836 |
|
|
2024
Q1 | – | Sell |
-10
| Closed | -$111 | – | 9379 |
|
|
2023
Q4 | $111 | Hold |
10
| – | – | ﹤0.01% | 8911 |
|
|
2023
Q3 | $132 | Buy |
+10
| New | +$134 | ﹤0.01% | 8817 |
|
|
2023
Q2 | – | Sell |
-10
| Closed | -$125 | – | 8976 |
|
|
2023
Q1 | $125 | Sell |
10
-210
| -95% | -$2.85K | ﹤0.01% | 9202 |
|
|
2022
Q4 | $3.6K | Buy |
220
+1
| +0.5% | +$16 | ﹤0.01% | 9481 |
|
|
2022
Q3 | $4K | Hold |
219
| – | – | ﹤0.01% | 9339 |
|
|
2022
Q2 | $4K | Sell |
219
-54
| -20% | -$907 | ﹤0.01% | 9047 |
|
|
2022
Q1 | $5K | Buy |
273
+191
| +233% | +$3.72K | ﹤0.01% | 9103 |
|
|
2021
Q4 | $2K | Buy |
82
+56
| +215% | +$1.36K | ﹤0.01% | 9783 |
|
|
2021
Q3 | $1K | Sell |
26
-385
| -94% | -$10.8K | ﹤0.01% | 9154 |
|
|
2021
Q2 | $12K | Buy |
411
+391
| +1,955% | +$13.2K | ﹤0.01% | 7870 |
|
|
2021
Q1 | $1K | Buy |
+20
| New | +$735 | ﹤0.01% | 8754 |
|
|
2020
Q2 | – | Sell |
-347
| Closed | -$6K | – | 7962 |
|
|
2020
Q1 | $6K | Sell |
347
-70
| -17% | -$1.66K | ﹤0.01% | 7209 |
|
|
2019
Q4 | $11K | Buy |
417
+1
| +0.2% | +$26 | ﹤0.01% | 7227 |
|
|
2019
Q3 | $10K | Hold |
416
| – | – | ﹤0.01% | 7153 |
|
|
2019
Q2 | $9K | Buy |
416
+40
| +11% | +$980 | ﹤0.01% | 7121 |
|
|
2019
Q1 | $11K | Buy |
376
+15
| +4% | +$478 | ﹤0.01% | 6737 |
|
|
2018
Q4 | $13K | Buy |
361
+150
| +71% | +$5.33K | ﹤0.01% | 7086 |
|
|
2018
Q3 | $7K | Buy |
211
+21
| +11% | +$740 | ﹤0.01% | 7323 |
|
|
2018
Q2 | $8K | Buy |
190
+93
| +96% | +$3.52K | ﹤0.01% | 7251 |
|
|
2018
Q1 | $3K | Buy |
+97
| New | +$2.85K | ﹤0.01% | 7408 |
|
|
2017
Q4 | – | Sell |
-354
| Closed | -$12K | – | 7852 |
|
|
2017
Q3 | $12K | Buy |
354
+274
| +343% | +$10.9K | ﹤0.01% | 6768 |
|
|
2017
Q2 | $3K | Sell |
80
-451
| -85% | -$18.4K | ﹤0.01% | 7280 |
|
|
2017
Q1 | $25K | Sell |
531
-532
| -50% | -$24.9K | ﹤0.01% | 5979 |
|
|
2016
Q4 | $49K | Buy |
+1,063
| New | +$46.8K | ﹤0.01% | 5846 |
|
|
2016
Q3 | – | Sell |
-60
| Closed | -$2K | – | 7682 |
|
|
2016
Q2 | $2K | Sell |
60
-105
| -64% | -$4.47K | ﹤0.01% | 7423 |
|
|
2016
Q1 | $8K | Sell |
165
-283
| -63% | -$13.4K | ﹤0.01% | 6777 |
|
|
2015
Q4 | $22K | Buy |
448
+49
| +12% | +$2.43K | ﹤0.01% | 6644 |
|
|
2015
Q3 | $19K | Buy |
399
+228
| +133% | +$12.4K | ﹤0.01% | 6738 |
|
|
2015
Q2 | $12K | Buy |
171
+73
| +74% | +$5.09K | ﹤0.01% | 7302 |
|
|
2015
Q1 | $5K | Buy |
98
+23
| +31% | +$1.58K | ﹤0.01% | 8084 |
|
|
2014
Q4 | $5K | Buy |
+75
| New | +$5.2K | ﹤0.01% | 8952 |
|
Other funds holding CCM
SP
SS
UBS Group's CCM Position: Q2 2026 in Review
UBS Group reduced its Concord Medical Services (CCM) stake by 19% in Q2 2026, selling an estimated $527 and leaving 500 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #9357.
UBS Group first reported a position in CCM in Q4 2014 and has held it in 40 quarters since. The position peaked at $389K in Q2 2025. 7 funds tracked by Wall St. Rank hold CCM as of Q2 2026.
- UBS Group held 500 shares of Concord Medical Services worth $2.36K as of Q2 2026.
- UBS Group sold 115 Concord Medical Services shares in Q2 2026, an estimated $527.
- Concord Medical Services made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9357 holding.
- UBS Group first reported a position in Concord Medical Services in Q4 2014 and has held it in 40 quarters since.
- UBS Group's Concord Medical Services position peaked at $389K in Q2 2025.
- 7 funds tracked by Wall St. Rank held Concord Medical Services as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.